• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两性霉素B的透析内给药:疗效与安全性的临床观察

Intradialytic administration of amphotericin B: clinical observations on efficacy and safety.

作者信息

Wood James E, Mahnensmith Mary P, Mahnensmith Rex L, Perazella Mark A

机构信息

Department of Medicine, Yale University School of Medicine, New Haven, CT 06520, USA.

出版信息

Am J Med Sci. 2004 Jan;327(1):5-8. doi: 10.1097/00000441-200401000-00002.

DOI:10.1097/00000441-200401000-00002
PMID:14722389
Abstract

BACKGROUND

Amphotericin B is used commonly to treat fungal infections. Unfortunately, little information exists regarding the use of intravenous amphotericin B in patients with end-stage renal disease (ESRD).

METHODS

We retrospectively reviewed the clinical course of patients receiving amphotericin B during hemodialysis (HD). Twenty-five episodes of systemic fungal infection occurring in 24 patients with ESRD treated with parenteral amphotericin B administered during HD were noted. Patients received a maintenance dose of 0.5 to 1.0 mg/kg amphotericin B intravenously thrice weekly during HD sessions. Twenty-three patients received either 500 or 1000 mg of amphotericin B, whereas 1 patient with AIDS received a total of 6,500 mg.

RESULTS

Intradialytic hypotension developed in 27.7% of HD sessions during treatment with amphotericin B compared with 28.8% of 20 HD sessions evaluated before initiation of amphotericin B therapy. Four patients exhibited a temperature rise greater than 38.8 degrees C during drug infusion (1 episode per patient). Increases in heart rate and ventricular ectopy were rare. Serum potassium concentrations as well as Kt/V and urea reduction ratio did not change significantly. All patients (except the patient with AIDS) resolved their respective fungal infections.

CONCLUSIONS

Intradialytic administration of amphotericin B was generally well tolerated. Our observations suggest that amphotericin B is effective and safe for outpatient intradialytic therapy when administered according to protocol.

摘要

背景

两性霉素B常用于治疗真菌感染。遗憾的是,关于终末期肾病(ESRD)患者使用静脉注射两性霉素B的信息很少。

方法

我们回顾性分析了接受血液透析(HD)期间使用两性霉素B的患者的临床病程。记录了24例接受HD期间静脉注射两性霉素B治疗的ESRD患者发生的25次全身性真菌感染。患者在HD期间每周三次静脉注射维持剂量为0.5至1.0mg/kg的两性霉素B。23例患者接受了500或1000mg的两性霉素B,而1例艾滋病患者共接受了6500mg。

结果

两性霉素B治疗期间,27.7%的HD疗程出现透析中低血压,而在两性霉素B治疗开始前评估的20个HD疗程中,这一比例为28.8%。4例患者在药物输注期间体温升高超过38.8℃(每位患者1次)。心率增加和室性早搏很少见。血清钾浓度以及Kt/V和尿素清除率没有明显变化。所有患者(艾滋病患者除外)均治愈了各自的真菌感染。

结论

透析中给予两性霉素B一般耐受性良好。我们的观察结果表明,按照方案给药时,两性霉素B对于门诊透析中治疗是有效且安全的。

相似文献

1
Intradialytic administration of amphotericin B: clinical observations on efficacy and safety.两性霉素B的透析内给药:疗效与安全性的临床观察
Am J Med Sci. 2004 Jan;327(1):5-8. doi: 10.1097/00000441-200401000-00002.
2
Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.卡泊芬净与两性霉素B脂质体用于持续发热和中性粒细胞减少患者的经验性抗真菌治疗比较
N Engl J Med. 2004 Sep 30;351(14):1391-402. doi: 10.1056/NEJMoa040446.
3
Implementation of clinical practice policy on the continuous intravenous administration of amphotericin B deoxycholate.两性霉素B去氧胆酸盐持续静脉给药临床实践政策的实施
J Med Assoc Thai. 2006 Nov;89 Suppl 5:S118-24.
4
Liposomal amphotericin B for the treatment of severe fungal infection.脂质体两性霉素B治疗严重真菌感染。
Dynamics. 2001 Spring;12(1):17-21.
5
Open label, randomised, comparative phase III safety and efficacy study with conventional amphotericin B and liposomal amphotericin B in patients with systemic fungal infection.一项开放标签、随机、比较性III期安全性和疗效研究,对比传统两性霉素B和脂质体两性霉素B治疗系统性真菌感染患者的效果。
J Assoc Physicians India. 2002 May;50(5):662-70.
6
Administration of lipid-emulsion versus conventional amphotericin B in patients with neutropenia.
Ann Pharmacother. 1995 Dec;29(12):1197-201. doi: 10.1177/106002809502901201.
7
Low-dose amphotericin B lipid complex vs. conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies--a randomized, controlled trial.低剂量两性霉素B脂质复合物与传统两性霉素B用于血液系统恶性肿瘤患者中性粒细胞减少性发热的经验性抗真菌治疗——一项随机对照试验
Eur J Haematol. 2004 May;72(5):342-7. doi: 10.1111/j.1600-0609.2004.00239.x.
8
Continuously infused amphotericin B deoxycholate for primary treatment of invasive fungal disease in acute myeloid leukaemia.持续输注两性霉素B去氧胆酸盐用于急性髓系白血病侵袭性真菌病的初始治疗。
Hematol Oncol. 2018 Apr;36(2):471-480. doi: 10.1002/hon.2500. Epub 2018 Feb 12.
9
Efficiency and safety of inhaled amphotericin B lipid complex (Abelcet) in the prophylaxis of invasive fungal infections following lung transplantation.吸入用两性霉素B脂质复合物(Abelcet)在肺移植后预防侵袭性真菌感染中的有效性和安全性。
Transplant Proc. 2008 Nov;40(9):3090-3. doi: 10.1016/j.transproceed.2008.09.020.
10
Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group.脂质体两性霉素B用于持续发热和中性粒细胞减少患者的经验性治疗。美国国立过敏和传染病研究所真菌病研究组。
N Engl J Med. 1999 Mar 11;340(10):764-71. doi: 10.1056/NEJM199903113401004.

引用本文的文献

1
A Case-Control Study on Mucormycosis in Tertiary Care Hospital, Bhopal.博帕尔三级医疗医院毛霉菌病的病例对照研究
Indian J Community Med. 2022 Jul-Sep;47(3):396-399. doi: 10.4103/ijcm.ijcm_1320_21. Epub 2022 Oct 10.
2
Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and Academy of Pulmonary Sciences, India.COVID-19 相关肺毛霉菌病的定义、诊断和管理:印度真菌感染研究论坛和肺病科学院的德尔菲共识声明。
Lancet Infect Dis. 2022 Sep;22(9):e240-e253. doi: 10.1016/S1473-3099(22)00124-4. Epub 2022 Apr 4.
3
Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of Literature.
冠状病毒病(新冠-19)相关毛霉菌病(CAM):病例报告及文献系统综述
Mycopathologia. 2021 May;186(2):289-298. doi: 10.1007/s11046-021-00528-2. Epub 2021 Feb 5.